Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation

Detalles Bibliográficos
Autores principales: Asawapanumas, Thiti, Chanswangphuwana, Chantiya, Watanaboonyongcharoen, Phandee, Rojnuckarin, Ponlapat, Bunworasate, Udomsak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059067/
https://www.ncbi.nlm.nih.gov/pubmed/35509968
http://dx.doi.org/10.1016/j.lrr.2022.100314
_version_ 1784698236499394560
author Asawapanumas, Thiti
Chanswangphuwana, Chantiya
Watanaboonyongcharoen, Phandee
Rojnuckarin, Ponlapat
Bunworasate, Udomsak
author_facet Asawapanumas, Thiti
Chanswangphuwana, Chantiya
Watanaboonyongcharoen, Phandee
Rojnuckarin, Ponlapat
Bunworasate, Udomsak
author_sort Asawapanumas, Thiti
collection PubMed
description
format Online
Article
Text
id pubmed-9059067
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90590672022-05-03 Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation Asawapanumas, Thiti Chanswangphuwana, Chantiya Watanaboonyongcharoen, Phandee Rojnuckarin, Ponlapat Bunworasate, Udomsak Leuk Res Rep Case Report Elsevier 2022-04-13 /pmc/articles/PMC9059067/ /pubmed/35509968 http://dx.doi.org/10.1016/j.lrr.2022.100314 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Asawapanumas, Thiti
Chanswangphuwana, Chantiya
Watanaboonyongcharoen, Phandee
Rojnuckarin, Ponlapat
Bunworasate, Udomsak
Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
title Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
title_full Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
title_fullStr Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
title_full_unstemmed Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
title_short Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
title_sort daratumumab as a frontline immunosuppression for pure red cell aplasia after major abo-mismatched allogeneic hematopoietic stem cell transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059067/
https://www.ncbi.nlm.nih.gov/pubmed/35509968
http://dx.doi.org/10.1016/j.lrr.2022.100314
work_keys_str_mv AT asawapanumasthiti daratumumabasafrontlineimmunosuppressionforpureredcellaplasiaaftermajorabomismatchedallogeneichematopoieticstemcelltransplantation
AT chanswangphuwanachantiya daratumumabasafrontlineimmunosuppressionforpureredcellaplasiaaftermajorabomismatchedallogeneichematopoieticstemcelltransplantation
AT watanaboonyongcharoenphandee daratumumabasafrontlineimmunosuppressionforpureredcellaplasiaaftermajorabomismatchedallogeneichematopoieticstemcelltransplantation
AT rojnuckarinponlapat daratumumabasafrontlineimmunosuppressionforpureredcellaplasiaaftermajorabomismatchedallogeneichematopoieticstemcelltransplantation
AT bunworasateudomsak daratumumabasafrontlineimmunosuppressionforpureredcellaplasiaaftermajorabomismatchedallogeneichematopoieticstemcelltransplantation

Ejemplares similares